| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 47 | 2023 | 3386 | 4.030 |
Why?
|
| Genetic Vectors | 38 | 2022 | 3420 | 2.920 |
Why?
|
| rac GTP-Binding Proteins | 13 | 2017 | 164 | 2.540 |
Why?
|
| Fanconi Anemia | 12 | 2013 | 319 | 2.300 |
Why?
|
| Anemia, Sickle Cell | 9 | 2023 | 1018 | 2.050 |
Why?
|
| Lentivirus | 8 | 2022 | 501 | 2.030 |
Why?
|
| Fetal Hemoglobin | 5 | 2022 | 341 | 1.970 |
Why?
|
| rho GTP-Binding Proteins | 6 | 2022 | 293 | 1.820 |
Why?
|
| Retroviridae | 15 | 2022 | 914 | 1.660 |
Why?
|
| p21-Activated Kinases | 3 | 2017 | 128 | 1.530 |
Why?
|
| Adrenoleukodystrophy | 4 | 2023 | 123 | 1.450 |
Why?
|
| Hematopoiesis | 12 | 2023 | 2072 | 1.430 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 23 | 2023 | 5442 | 1.410 |
Why?
|
| gamma-Globins | 5 | 2022 | 95 | 1.300 |
Why?
|
| National Institutes of Health (U.S.) | 8 | 2010 | 780 | 1.290 |
Why?
|
| Adenosine Deaminase | 9 | 2017 | 241 | 1.250 |
Why?
|
| Hematology | 4 | 2017 | 221 | 1.130 |
Why?
|
| Anemia, Aplastic | 3 | 2020 | 226 | 1.070 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2017 | 223 | 1.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2018 | 95 | 1.010 |
Why?
|
| Transduction, Genetic | 6 | 2015 | 913 | 1.000 |
Why?
|
| beta-Thalassemia | 3 | 2020 | 225 | 0.970 |
Why?
|
| Biological Assay | 2 | 2016 | 652 | 0.850 |
Why?
|
| Gene Transfer Techniques | 11 | 2014 | 1224 | 0.850 |
Why?
|
| Hemoglobinopathies | 1 | 2022 | 96 | 0.800 |
Why?
|
| Transcription Factors | 9 | 2022 | 12208 | 0.760 |
Why?
|
| cdc42 GTP-Binding Protein | 3 | 2020 | 194 | 0.760 |
Why?
|
| RNA Interference | 3 | 2020 | 2889 | 0.750 |
Why?
|
| Wiskott-Aldrich Syndrome | 3 | 2023 | 131 | 0.740 |
Why?
|
| Advisory Committees | 3 | 2009 | 775 | 0.710 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 2 | 2010 | 22 | 0.690 |
Why?
|
| Awards and Prizes | 2 | 2017 | 375 | 0.690 |
Why?
|
| Dependovirus | 4 | 2008 | 706 | 0.680 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 612 | 0.640 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2018 | 66 | 0.630 |
Why?
|
| Interleukin-11 | 1 | 2018 | 63 | 0.620 |
Why?
|
| Flow Cytometry | 5 | 2016 | 5974 | 0.620 |
Why?
|
| Cell Movement | 9 | 2016 | 5217 | 0.590 |
Why?
|
| Antigens, CD34 | 8 | 2017 | 657 | 0.590 |
Why?
|
| Lymphoma | 4 | 2022 | 1877 | 0.580 |
Why?
|
| Repressor Proteins | 5 | 2022 | 3023 | 0.580 |
Why?
|
| Cytoskeleton | 3 | 2016 | 1185 | 0.560 |
Why?
|
| Mice | 56 | 2022 | 81183 | 0.560 |
Why?
|
| Bone Marrow Transplantation | 5 | 2020 | 2765 | 0.540 |
Why?
|
| Animals | 72 | 2022 | 168757 | 0.540 |
Why?
|
| Myeloid Cells | 1 | 2020 | 810 | 0.520 |
Why?
|
| Neutrophils | 4 | 2018 | 3719 | 0.520 |
Why?
|
| Transgenes | 4 | 2014 | 1009 | 0.510 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 3505 | 0.510 |
Why?
|
| Research Support as Topic | 4 | 2008 | 705 | 0.500 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 3 | 2012 | 46 | 0.500 |
Why?
|
| Neuropeptides | 6 | 2011 | 942 | 0.500 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 2 | 2023 | 160 | 0.490 |
Why?
|
| Mutagenesis, Insertional | 7 | 2007 | 655 | 0.490 |
Why?
|
| Bone Marrow | 10 | 2016 | 2948 | 0.490 |
Why?
|
| Stem Cells | 4 | 2018 | 3567 | 0.480 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 4149 | 0.480 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 560 | 0.480 |
Why?
|
| Zinc Fingers | 1 | 2016 | 585 | 0.480 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 2 | 2014 | 23 | 0.470 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2013 | 14 | 0.470 |
Why?
|
| Medical Oncology | 3 | 2017 | 2265 | 0.460 |
Why?
|
| Mice, Knockout | 17 | 2022 | 14557 | 0.460 |
Why?
|
| Clinical Trials as Topic | 10 | 2017 | 7913 | 0.450 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2013 | 42 | 0.450 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 547 | 0.450 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2014 | 93 | 0.450 |
Why?
|
| Gene Knockdown Techniques | 5 | 2020 | 1655 | 0.450 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 100 | 0.430 |
Why?
|
| Cell Lineage | 5 | 2016 | 2504 | 0.420 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 3 | 2007 | 85 | 0.420 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 346 | 0.420 |
Why?
|
| Chemokines | 1 | 2016 | 970 | 0.410 |
Why?
|
| Pluripotent Stem Cells | 2 | 2009 | 795 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2014 | 776 | 0.400 |
Why?
|
| Cell Communication | 3 | 2016 | 1621 | 0.390 |
Why?
|
| rac1 GTP-Binding Protein | 8 | 2011 | 237 | 0.380 |
Why?
|
| Carrier Proteins | 6 | 2022 | 5021 | 0.380 |
Why?
|
| Humans | 111 | 2023 | 744343 | 0.380 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2012 | 1736 | 0.380 |
Why?
|
| Financing, Organized | 2 | 2010 | 202 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 22 | 2018 | 21827 | 0.370 |
Why?
|
| Congresses as Topic | 4 | 2014 | 764 | 0.360 |
Why?
|
| Neoplastic Stem Cells | 3 | 2014 | 1376 | 0.360 |
Why?
|
| Mice, SCID | 5 | 2016 | 2716 | 0.350 |
Why?
|
| Gene Silencing | 2 | 2015 | 1538 | 0.340 |
Why?
|
| Bone Marrow Cells | 7 | 2014 | 2513 | 0.340 |
Why?
|
| Stem Cell Factor | 3 | 2011 | 219 | 0.340 |
Why?
|
| Education, Medical, Graduate | 2 | 2012 | 2291 | 0.340 |
Why?
|
| Embryo Research | 1 | 2009 | 60 | 0.340 |
Why?
|
| Nuclear Proteins | 4 | 2022 | 5853 | 0.330 |
Why?
|
| Signal Transduction | 11 | 2022 | 23403 | 0.330 |
Why?
|
| Spumavirus | 1 | 2008 | 16 | 0.320 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2008 | 241 | 0.320 |
Why?
|
| Lysosomes | 1 | 2013 | 893 | 0.320 |
Why?
|
| Mice, Inbred NOD | 5 | 2016 | 1878 | 0.320 |
Why?
|
| Transposases | 1 | 2008 | 107 | 0.320 |
Why?
|
| Bone Development | 1 | 2011 | 483 | 0.320 |
Why?
|
| Cells, Cultured | 13 | 2018 | 19229 | 0.320 |
Why?
|
| Academies and Institutes | 1 | 2010 | 317 | 0.320 |
Why?
|
| Patient Selection | 1 | 2020 | 4215 | 0.310 |
Why?
|
| Wnt Proteins | 2 | 2011 | 721 | 0.310 |
Why?
|
| Pediatrics | 3 | 2012 | 3475 | 0.310 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 402 | 0.310 |
Why?
|
| Societies, Medical | 3 | 2010 | 3743 | 0.310 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2007 | 60 | 0.300 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2018 | 227 | 0.300 |
Why?
|
| Dog Diseases | 1 | 2008 | 138 | 0.300 |
Why?
|
| Publications | 1 | 2009 | 195 | 0.290 |
Why?
|
| Sirolimus | 1 | 2014 | 1564 | 0.290 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2008 | 689 | 0.290 |
Why?
|
| DNA Modification Methylases | 1 | 2007 | 206 | 0.280 |
Why?
|
| Methenamine | 1 | 2005 | 5 | 0.280 |
Why?
|
| Gammaretrovirus | 2 | 2017 | 54 | 0.280 |
Why?
|
| Oxymetazoline | 1 | 2005 | 5 | 0.280 |
Why?
|
| Hippurates | 1 | 2005 | 16 | 0.280 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2453 | 0.270 |
Why?
|
| Nasal Decongestants | 1 | 2005 | 28 | 0.270 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2005 | 28 | 0.270 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2004 | 166 | 0.270 |
Why?
|
| Osteoblasts | 1 | 2011 | 1166 | 0.270 |
Why?
|
| Mandelic Acids | 1 | 2005 | 47 | 0.270 |
Why?
|
| Cell Separation | 2 | 2014 | 1751 | 0.270 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2007 | 434 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2014 | 4554 | 0.260 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 349 | 0.260 |
Why?
|
| Triamcinolone Acetonide | 1 | 2005 | 101 | 0.260 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2005 | 100 | 0.260 |
Why?
|
| Nucleoside Deaminases | 4 | 1989 | 58 | 0.250 |
Why?
|
| Transfection | 9 | 2014 | 5892 | 0.250 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2005 | 164 | 0.250 |
Why?
|
| Codon, Nonsense | 1 | 2006 | 281 | 0.250 |
Why?
|
| DNA Transposable Elements | 1 | 2008 | 748 | 0.250 |
Why?
|
| Blotting, Western | 4 | 2014 | 5179 | 0.240 |
Why?
|
| Mice, Transgenic | 11 | 2022 | 9734 | 0.240 |
Why?
|
| Transplantation, Autologous | 2 | 2020 | 2124 | 0.240 |
Why?
|
| Retinal Degeneration | 1 | 2008 | 415 | 0.240 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2007 | 651 | 0.240 |
Why?
|
| Hospitals, Pediatric | 2 | 2010 | 1775 | 0.230 |
Why?
|
| Leukemia, T-Cell | 1 | 2004 | 104 | 0.230 |
Why?
|
| Jurkat Cells | 2 | 2016 | 743 | 0.230 |
Why?
|
| Gene Expression | 8 | 2017 | 7799 | 0.220 |
Why?
|
| Leukemia | 2 | 2016 | 1511 | 0.220 |
Why?
|
| History, 20th Century | 3 | 2017 | 2740 | 0.220 |
Why?
|
| Genes, Lethal | 1 | 2003 | 242 | 0.220 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1405 | 0.220 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 10180 | 0.210 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2022 | 119 | 0.210 |
Why?
|
| Oncolytic Viruses | 1 | 2006 | 327 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4420 | 0.210 |
Why?
|
| Mutagenesis | 1 | 2006 | 1266 | 0.210 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2005 | 469 | 0.210 |
Why?
|
| Gene Duplication | 1 | 2003 | 329 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1076 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1790 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1294 | 0.200 |
Why?
|
| Anemia, Hemolytic | 1 | 2022 | 168 | 0.200 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10481 | 0.200 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 122 | 0.200 |
Why?
|
| Myeloproliferative Disorders | 1 | 2007 | 606 | 0.200 |
Why?
|
| HIV | 1 | 2009 | 1604 | 0.200 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 9648 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2022 | 193 | 0.200 |
Why?
|
| Eczema | 1 | 2023 | 231 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2017 | 1534 | 0.190 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 1596 | 0.190 |
Why?
|
| Oncolytic Virotherapy | 1 | 2006 | 498 | 0.190 |
Why?
|
| Phenotype | 8 | 2022 | 16365 | 0.190 |
Why?
|
| Herpesvirus 1, Human | 1 | 2006 | 743 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2008 | 2849 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2232 | 0.180 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 18029 | 0.180 |
Why?
|
| Erythropoiesis | 3 | 2014 | 705 | 0.180 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 3586 | 0.180 |
Why?
|
| Proto-Oncogenes | 3 | 2006 | 321 | 0.170 |
Why?
|
| Biomedical Research | 2 | 2005 | 3309 | 0.170 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2014 | 3523 | 0.170 |
Why?
|
| Chemokine CXCL12 | 2 | 2012 | 464 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2421 | 0.170 |
Why?
|
| Protein Transport | 2 | 2016 | 1988 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2015 | 3752 | 0.170 |
Why?
|
| Drug Approval | 1 | 2005 | 742 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2020 | 8324 | 0.170 |
Why?
|
| Child | 12 | 2021 | 77709 | 0.160 |
Why?
|
| Reticulocytes | 2 | 2012 | 290 | 0.160 |
Why?
|
| Viral Proteins | 1 | 2006 | 1900 | 0.160 |
Why?
|
| Apoptosis | 6 | 2018 | 9727 | 0.160 |
Why?
|
| Virus Replication | 2 | 2022 | 2534 | 0.160 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 2077 | 0.160 |
Why?
|
| Enzyme Activation | 2 | 2016 | 3701 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 3557 | 0.160 |
Why?
|
| Genetic Engineering | 4 | 2007 | 951 | 0.160 |
Why?
|
| Mutation | 10 | 2023 | 29786 | 0.160 |
Why?
|
| Gene Rearrangement | 1 | 2003 | 1179 | 0.150 |
Why?
|
| Primary Myelofibrosis | 1 | 2020 | 215 | 0.150 |
Why?
|
| Blood Component Removal | 1 | 2018 | 125 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2020 | 3002 | 0.150 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 249 | 0.150 |
Why?
|
| Warfarin | 2 | 2016 | 1496 | 0.150 |
Why?
|
| Retina | 1 | 2008 | 2616 | 0.150 |
Why?
|
| Exons | 1 | 2003 | 2437 | 0.150 |
Why?
|
| Base Sequence | 6 | 2019 | 12797 | 0.150 |
Why?
|
| Infant | 9 | 2022 | 35136 | 0.140 |
Why?
|
| United States | 13 | 2010 | 69872 | 0.140 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8642 | 0.140 |
Why?
|
| Consensus | 1 | 2006 | 2959 | 0.140 |
Why?
|
| Cell Line | 5 | 2022 | 15997 | 0.140 |
Why?
|
| ras Proteins | 1 | 2022 | 1060 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4186 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2020 | 591 | 0.130 |
Why?
|
| Erythrocytes | 2 | 2016 | 2455 | 0.130 |
Why?
|
| Neoplasms | 5 | 2023 | 21683 | 0.130 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 115 | 0.130 |
Why?
|
| Chimerism | 1 | 2016 | 158 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2016 | 3144 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.130 |
Why?
|
| Cell Shape | 1 | 2016 | 375 | 0.130 |
Why?
|
| Gene Order | 1 | 2015 | 176 | 0.130 |
Why?
|
| Spleen | 3 | 2012 | 2362 | 0.130 |
Why?
|
| Solutions | 2 | 2005 | 426 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 2759 | 0.130 |
Why?
|
| Indicators and Reagents | 2 | 2005 | 462 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 648 | 0.120 |
Why?
|
| Erythroblasts | 2 | 2012 | 150 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
| Genes | 2 | 1989 | 1893 | 0.120 |
Why?
|
| Siblings | 2 | 2020 | 854 | 0.120 |
Why?
|
| Syndrome | 1 | 2020 | 3251 | 0.120 |
Why?
|
| Prenylation | 1 | 2013 | 37 | 0.120 |
Why?
|
| Oxandrolone | 1 | 2013 | 23 | 0.120 |
Why?
|
| Polyethyleneimine | 1 | 2014 | 63 | 0.120 |
Why?
|
| Erythroid Cells | 1 | 2015 | 238 | 0.120 |
Why?
|
| Adolescent | 9 | 2020 | 85781 | 0.120 |
Why?
|
| Prognosis | 3 | 2020 | 29063 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2022 | 2942 | 0.110 |
Why?
|
| Male | 22 | 2023 | 350118 | 0.110 |
Why?
|
| Metalloproteins | 2 | 2004 | 100 | 0.110 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2016 | 153 | 0.110 |
Why?
|
| GATA1 Transcription Factor | 1 | 2014 | 293 | 0.110 |
Why?
|
| Research Personnel | 2 | 2010 | 573 | 0.110 |
Why?
|
| Calcium Phosphates | 1 | 2014 | 171 | 0.110 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2013 | 102 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1994 | 1085 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 534 | 0.110 |
Why?
|
| Niacinamide | 1 | 2014 | 417 | 0.110 |
Why?
|
| Metaphase | 1 | 2012 | 151 | 0.110 |
Why?
|
| Azacitidine | 1 | 2014 | 347 | 0.110 |
Why?
|
| Phagocytes | 2 | 2010 | 297 | 0.110 |
Why?
|
| Chemokine CXCL13 | 1 | 2012 | 54 | 0.100 |
Why?
|
| Dioxygenases | 1 | 2014 | 316 | 0.100 |
Why?
|
| Retinal Telangiectasis | 1 | 2012 | 24 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2012 | 5788 | 0.100 |
Why?
|
| Embryoid Bodies | 1 | 2012 | 67 | 0.100 |
Why?
|
| Safety | 2 | 2007 | 1186 | 0.100 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 492 | 0.100 |
Why?
|
| Reference Standards | 2 | 2005 | 1025 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 976 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 1572 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 557 | 0.100 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2014 | 88 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 913 | 0.100 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2011 | 35 | 0.100 |
Why?
|
| Cell Differentiation | 6 | 2012 | 11483 | 0.100 |
Why?
|
| Aminoquinolines | 2 | 2011 | 109 | 0.100 |
Why?
|
| Dyskeratosis Congenita | 1 | 2012 | 72 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2012 | 4161 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2012 | 116 | 0.100 |
Why?
|
| Polycythemia Vera | 1 | 2013 | 164 | 0.100 |
Why?
|
| Bone Marrow Diseases | 2 | 2013 | 231 | 0.100 |
Why?
|
| Protein Binding | 3 | 2016 | 9386 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2018 | 1640 | 0.100 |
Why?
|
| Actins | 2 | 2016 | 2121 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 936 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 599 | 0.100 |
Why?
|
| Anabolic Agents | 1 | 2013 | 247 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2013 | 786 | 0.100 |
Why?
|
| Child, Preschool | 6 | 2021 | 41006 | 0.100 |
Why?
|
| Microscopy, Video | 1 | 2011 | 245 | 0.090 |
Why?
|
| Pyrimidines | 3 | 2014 | 2942 | 0.090 |
Why?
|
| Histones | 2 | 2018 | 2599 | 0.090 |
Why?
|
| Erythroid Precursor Cells | 2 | 2019 | 218 | 0.090 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2006 | 174 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2016 | 4599 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6171 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 269 | 0.090 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 457 | 0.090 |
Why?
|
| North America | 1 | 2013 | 1249 | 0.090 |
Why?
|
| Women's Health Services | 1 | 2010 | 93 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.090 |
Why?
|
| Cytarabine | 1 | 2012 | 692 | 0.090 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 252 | 0.090 |
Why?
|
| Janus Kinase 2 | 1 | 2013 | 528 | 0.090 |
Why?
|
| Hematopoietic System | 1 | 2010 | 109 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
| Telomerase | 1 | 2014 | 730 | 0.090 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2009 | 21 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 428 | 0.090 |
Why?
|
| Stomach | 1 | 2014 | 697 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 2839 | 0.090 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 241 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2010 | 188 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 675 | 0.080 |
Why?
|
| Fluorouracil | 1 | 2014 | 1619 | 0.080 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 2085 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2013 | 1539 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 895 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2010 | 1352 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 4776 | 0.080 |
Why?
|
| Cell Survival | 3 | 2016 | 5882 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 1994 | 1758 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 1827 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2014 | 2050 | 0.080 |
Why?
|
| Mesonephros | 1 | 2007 | 40 | 0.080 |
Why?
|
| Terminal Repeat Sequences | 1 | 2008 | 72 | 0.080 |
Why?
|
| alpha-Synuclein | 1 | 2014 | 723 | 0.080 |
Why?
|
| Esophagus | 1 | 2014 | 1019 | 0.080 |
Why?
|
| Yolk Sac | 1 | 2007 | 75 | 0.080 |
Why?
|
| Female | 16 | 2022 | 380194 | 0.080 |
Why?
|
| Oncogenes | 1 | 1994 | 1265 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1783 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1990 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2020 | 3444 | 0.070 |
Why?
|
| Mitomycin | 1 | 2008 | 259 | 0.070 |
Why?
|
| Graft Survival | 2 | 2009 | 3737 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 5867 | 0.070 |
Why?
|
| Newcastle disease virus | 1 | 2006 | 23 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1483 | 0.070 |
Why?
|
| Bibliometrics | 1 | 2010 | 339 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 389 | 0.070 |
Why?
|
| Mast Cells | 1 | 2014 | 1544 | 0.070 |
Why?
|
| Poxviridae | 1 | 2006 | 37 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2011 | 13033 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3846 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 595 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 16689 | 0.070 |
Why?
|
| Investigational New Drug Application | 1 | 2005 | 6 | 0.070 |
Why?
|
| Indoles | 1 | 2014 | 1839 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2004 | 2916 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2011 | 1355 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2011 | 1539 | 0.070 |
Why?
|
| Deficiency Diseases | 1 | 2006 | 72 | 0.070 |
Why?
|
| DNA Probes | 1 | 2007 | 560 | 0.070 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2005 | 220 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 305 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39050 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1142 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1813 | 0.070 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 1 | 2005 | 117 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2011 | 8436 | 0.070 |
Why?
|
| Dogs | 2 | 2008 | 3912 | 0.070 |
Why?
|
| Tablets | 1 | 2005 | 145 | 0.070 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2007 | 323 | 0.070 |
Why?
|
| Drug Stability | 1 | 2005 | 291 | 0.070 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2006 | 170 | 0.060 |
Why?
|
| Serotyping | 1 | 2005 | 338 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10943 | 0.060 |
Why?
|
| Ohio | 1 | 2005 | 337 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1519 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2020 | 2967 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2006 | 245 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 442 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 1994 | 2440 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1730 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 1866 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2564 | 0.060 |
Why?
|
| Group Processes | 1 | 2006 | 225 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 562 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2005 | 281 | 0.060 |
Why?
|
| Research Design | 3 | 2016 | 5987 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1434 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2007 | 665 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2005 | 446 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 463 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2012 | 2751 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 707 | 0.060 |
Why?
|
| Mice, Inbred C3H | 3 | 1991 | 964 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 2957 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2013 | 3748 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 6489 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2005 | 438 | 0.060 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 442 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1581 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3086 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3798 | 0.060 |
Why?
|
| Aerosols | 1 | 2005 | 625 | 0.060 |
Why?
|
| Primates | 1 | 2005 | 545 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2969 | 0.050 |
Why?
|
| Antigens, CD | 1 | 1993 | 4026 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2007 | 711 | 0.050 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2022 | 29 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2006 | 802 | 0.050 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2018 | 272 | 0.050 |
Why?
|
| beta-Globins | 1 | 2022 | 113 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2010 | 1181 | 0.050 |
Why?
|
| Europe | 1 | 2009 | 3339 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 573 | 0.050 |
Why?
|
| Gene Expression Regulation | 5 | 2006 | 12072 | 0.050 |
Why?
|
| DNA Damage | 1 | 2012 | 2432 | 0.050 |
Why?
|
| Heterozygote | 2 | 2022 | 2804 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2005 | 430 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1986 | 587 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 1832 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3255 | 0.050 |
Why?
|
| Cytokines | 2 | 2021 | 7322 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 19905 | 0.050 |
Why?
|
| Introns | 1 | 2003 | 991 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 725 | 0.050 |
Why?
|
| Time Factors | 5 | 2011 | 40075 | 0.050 |
Why?
|
| Skin | 1 | 2014 | 4364 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2703 | 0.050 |
Why?
|
| Clone Cells | 1 | 2023 | 1692 | 0.050 |
Why?
|
| Liver | 2 | 2007 | 7474 | 0.040 |
Why?
|
| Forecasting | 1 | 2009 | 2951 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2088 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
| Survival Rate | 2 | 2011 | 12788 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3703 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9438 | 0.040 |
Why?
|
| Germ Cells | 1 | 2003 | 631 | 0.040 |
Why?
|
| Program Development | 1 | 2005 | 1316 | 0.040 |
Why?
|
| Adult | 4 | 2020 | 214055 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1097 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4204 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2019 | 13815 | 0.040 |
Why?
|
| Internet | 2 | 2016 | 3064 | 0.040 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 184 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2018 | 195 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4462 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 279 | 0.040 |
Why?
|
| Benzylamines | 1 | 2018 | 223 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 1584 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 143 | 0.040 |
Why?
|
| Boston | 1 | 2010 | 9313 | 0.040 |
Why?
|
| Moloney murine leukemia virus | 2 | 1987 | 139 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2022 | 25625 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 1994 | 4320 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 712 | 0.040 |
Why?
|
| Phylogeny | 1 | 2023 | 2803 | 0.030 |
Why?
|
| Phosphoglycerate Kinase | 2 | 1993 | 68 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 2016 | 246 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1994 | 18111 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 387 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 426 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1994 | 1581 | 0.030 |
Why?
|
| Social Participation | 1 | 2016 | 173 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 63114 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2004 | 4217 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 367 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 222 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 477 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1341 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1993 | 102 | 0.030 |
Why?
|
| Superoxides | 1 | 1995 | 387 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1994 | 51 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1880 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2005 | 2958 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 755 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 380 | 0.030 |
Why?
|
| Piperazines | 2 | 2016 | 2488 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 803 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 1994 | 298 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1987 | 7722 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2503 | 0.030 |
Why?
|
| Models, Biological | 1 | 2009 | 9583 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 3712 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1101 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5172 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2008 | 1152 | 0.030 |
Why?
|
| Proviruses | 1 | 1993 | 318 | 0.030 |
Why?
|
| Helper Viruses | 1 | 1991 | 58 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 687 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 809 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2014 | 572 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2013 | 365 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2429 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2016 | 1460 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 413 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2011 | 172 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 203 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 500 | 0.020 |
Why?
|
| Gene Library | 1 | 1993 | 1074 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2011 | 411 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2010 | 127 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1989 | 356 | 0.020 |
Why?
|
| DNA Primers | 1 | 1993 | 2892 | 0.020 |
Why?
|
| Muscles | 1 | 1994 | 1614 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1994 | 1124 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 7279 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2010 | 403 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1791 | 0.020 |
Why?
|
| Pituitary Hormones, Anterior | 1 | 2007 | 65 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2008 | 135 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 2118 | 0.020 |
Why?
|
| Dwarfism, Pituitary | 1 | 2007 | 46 | 0.020 |
Why?
|
| Mice, Nude | 1 | 1994 | 3689 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 913 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1993 | 2375 | 0.020 |
Why?
|
| Reticulocytosis | 1 | 2006 | 10 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2007 | 129 | 0.020 |
Why?
|
| Puberty, Delayed | 1 | 2007 | 115 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3420 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 509 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11524 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 216 | 0.020 |
Why?
|
| Spectrin | 1 | 2006 | 177 | 0.020 |
Why?
|
| Microtubules | 1 | 2012 | 1090 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1799 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 910 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.020 |
Why?
|
| Cephalometry | 1 | 2007 | 382 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 648 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 424 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1526 | 0.020 |
Why?
|
| Hypopituitarism | 1 | 2007 | 254 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2006 | 249 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 390 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 2008 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 880 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3589 | 0.010 |
Why?
|
| Virion | 1 | 1986 | 433 | 0.010 |
Why?
|
| Carmustine | 1 | 2003 | 137 | 0.010 |
Why?
|
| DNA | 2 | 1989 | 7301 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 1986 | 262 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1991 | 1226 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2382 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 712 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2007 | 577 | 0.010 |
Why?
|
| Microcephaly | 1 | 2007 | 432 | 0.010 |
Why?
|
| Alleles | 2 | 2010 | 6933 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2005 | 436 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12026 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 1119 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 23338 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1620 | 0.010 |
Why?
|
| Organ Size | 1 | 2007 | 2252 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2007 | 683 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2011 | 1938 | 0.010 |
Why?
|
| Plasmids | 1 | 1987 | 2307 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2008 | 1904 | 0.010 |
Why?
|
| Cell Division | 1 | 2008 | 4568 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2003 | 612 | 0.010 |
Why?
|
| Body Height | 1 | 2007 | 1577 | 0.010 |
Why?
|
| Macrophages | 2 | 2011 | 5655 | 0.010 |
Why?
|
| Myocardium | 1 | 1994 | 4776 | 0.010 |
Why?
|
| Risk Factors | 2 | 2003 | 72290 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1826 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2109 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 2015 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2540 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8428 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1986 | 2617 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13695 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2171 | 0.010 |
Why?
|
| Anemia | 1 | 2006 | 1506 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2003 | 1598 | 0.010 |
Why?
|
| Immunity | 1 | 2003 | 1012 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7149 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1986 | 3494 | 0.010 |
Why?
|
| Cytochrome b Group | 1 | 1995 | 60 | 0.010 |
Why?
|
| Lung | 1 | 1994 | 9856 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 12804 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1995 | 122 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 1995 | 150 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3864 | 0.010 |
Why?
|
| Proteins | 1 | 2008 | 6103 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1995 | 235 | 0.010 |
Why?
|
| Peritonitis | 1 | 1995 | 365 | 0.010 |
Why?
|
| X Chromosome | 1 | 1995 | 814 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1991 | 295 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21746 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1995 | 2421 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20129 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1991 | 11124 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1995 | 1451 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1987 | 565 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1995 | 1400 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 213383 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 35421 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1987 | 6622 | 0.000 |
Why?
|